000 01446 a2200433 4500
005 20250513055412.0
264 0 _c19940819
008 199408s 0 0 eng d
022 _a0031-6970
024 7 _a10.1007/BF00199880
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKeränen, T
245 0 0 _aInhibition of soluble catechol-O-methyltransferase and single-dose pharmacokinetics after oral and intravenous administration of entacapone.
_h[electronic resource]
260 _bEuropean journal of clinical pharmacology
_c1994
300 _a151-7 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdministration, Oral
650 0 4 _aAdult
650 0 4 _aAnalysis of Variance
650 0 4 _aCatechol O-Methyltransferase Inhibitors
650 0 4 _aCatechols
_xadministration & dosage
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aErythrocytes
_xenzymology
650 0 4 _aHumans
650 0 4 _aInjections, Intravenous
650 0 4 _aMale
650 0 4 _aNitriles
650 0 4 _aReference Values
700 1 _aGordin, A
700 1 _aKarlsson, M
700 1 _aKorpela, K
700 1 _aPentikäinen, P J
700 1 _aRita, H
700 1 _aSchultz, E
700 1 _aSeppälä, L
700 1 _aWikberg, T
773 0 _tEuropean journal of clinical pharmacology
_gvol. 46
_gno. 2
_gp. 151-7
856 4 0 _uhttps://doi.org/10.1007/BF00199880
_zAvailable from publisher's website
999 _c8038862
_d8038862